|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
35,410,000 |
Market
Cap: |
13.66(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$206.89 - $413.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 463 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
775,132 |
1,954,537 |
3,671,939 |
3,760,365 |
Total Sell Value |
$315,716,326 |
$777,957,532 |
$1,216,956,934 |
$1,236,631,446 |
Total People Sold |
5 |
6 |
8 |
8 |
Total Sell Transactions |
29 |
58 |
97 |
104 |
End Date |
2024-03-02 |
2023-11-30 |
2023-06-01 |
2022-06-01 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Troendle August J. |
CEO |
|
2021-12-27 |
4 |
AS |
$226.11 |
$8,856,955 |
I/I |
(39,171) |
5,577,414 |
|
-39% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-27 |
4 |
AS |
$226.11 |
$8,856,955 |
D/D |
(39,171) |
5,577,414 |
|
-39% |
|
Troendle August J. |
CEO |
|
2021-12-23 |
4 |
AS |
$223.19 |
$5,095,428 |
I/I |
(22,830) |
5,616,585 |
|
-36% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-23 |
4 |
AS |
$223.19 |
$5,095,428 |
D/D |
(22,830) |
5,616,585 |
|
-36% |
|
Troendle August J. |
CEO |
|
2021-12-22 |
4 |
AS |
$220.50 |
$8,590,680 |
I/I |
(38,960) |
5,639,415 |
|
-38% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-22 |
4 |
AS |
$220.50 |
$8,590,680 |
D/D |
(38,960) |
5,639,415 |
|
-38% |
|
Troendle August J. |
CEO |
|
2021-12-21 |
4 |
AS |
$215.17 |
$3,901,678 |
I/I |
(18,133) |
5,678,375 |
|
-37% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-21 |
4 |
AS |
$215.17 |
$3,901,678 |
D/D |
(18,133) |
5,678,375 |
|
-37% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-20 |
4 |
AS |
$212.57 |
$4,832,566 |
D/D |
(22,734) |
5,696,508 |
|
-37% |
|
Troendle August J. |
CEO |
|
2021-12-20 |
4 |
AS |
$212.57 |
$4,832,566 |
I/I |
(22,734) |
5,696,508 |
|
-37% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-17 |
4 |
AS |
$213.59 |
$6,536,922 |
D/D |
(30,605) |
5,719,242 |
|
-38% |
|
Troendle August J. |
CEO |
|
2021-12-17 |
4 |
AS |
$213.59 |
$6,536,922 |
I/I |
(30,605) |
5,719,242 |
|
-38% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-16 |
4 |
AS |
$210.22 |
$1,252,701 |
D/D |
(5,959) |
5,749,847 |
|
-37% |
|
Troendle August J. |
CEO |
|
2021-12-16 |
4 |
AS |
$210.22 |
$1,252,701 |
I/I |
(5,959) |
5,749,847 |
|
-37% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-15 |
4 |
AS |
$210.28 |
$509,719 |
D/D |
(2,424) |
5,755,806 |
|
-38% |
|
Troendle August J. |
CEO |
|
2021-12-15 |
4 |
AS |
$210.28 |
$509,719 |
I/I |
(2,424) |
5,755,806 |
|
-38% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-10 |
4 |
AS |
$210.20 |
$64,952 |
D/D |
(309) |
5,758,230 |
|
-26% |
|
Troendle August J. |
CEO |
|
2021-12-10 |
4 |
AS |
$210.20 |
$64,952 |
I/I |
(309) |
5,758,230 |
|
-26% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-09 |
4 |
AS |
$212.13 |
$3,180,677 |
D/D |
(14,994) |
5,758,539 |
|
-26% |
|
Troendle August J. |
CEO |
|
2021-12-09 |
4 |
AS |
$212.13 |
$3,180,677 |
I/I |
(14,994) |
5,758,539 |
|
-26% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-08 |
4 |
AS |
$212.89 |
$3,378,777 |
D/D |
(15,871) |
5,773,533 |
|
-25% |
|
Troendle August J. |
CEO |
|
2021-12-08 |
4 |
AS |
$212.89 |
$3,378,777 |
I/I |
(15,871) |
5,773,533 |
|
-25% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-07 |
4 |
AS |
$211.78 |
$3,922,166 |
D/D |
(18,520) |
5,789,404 |
|
-27% |
|
Troendle August J. |
CEO |
|
2021-12-07 |
4 |
AS |
$211.78 |
$3,922,166 |
I/I |
(18,520) |
5,789,404 |
|
-27% |
|
Medpace Investors, Llc |
10% Owner |
|
2021-12-03 |
4 |
AS |
$211.48 |
$84,592 |
D/D |
(400) |
5,807,924 |
|
-23% |
|
247 Records found
|
|
Page 3 of 10 |
|
|